|1.||Becker-Pauly, Christoph: 14 articles (08/2015 - 05/2007)|
|2.||Bond, Judith S: 14 articles (03/2014 - 02/2003)|
|3.||Stöcker, Walter: 10 articles (12/2012 - 10/2002)|
|4.||Sterchi, Erwin E: 10 articles (10/2012 - 10/2002)|
|5.||Lottaz, Daniel: 7 articles (01/2011 - 10/2002)|
|6.||Matters, Gail L: 5 articles (02/2011 - 01/2005)|
|7.||Arnold, Philipp: 3 articles (08/2015 - 05/2015)|
|8.||Prox, Johannes: 3 articles (08/2015 - 05/2015)|
|9.||Shah, Sudhir V: 3 articles (05/2013 - 03/2002)|
|10.||Banerjee, Sanjita: 3 articles (02/2011 - 06/2005)|
|1.||Alcoholic Fatty Liver
06/01/2012 - "To study the protective effects of tiopronin against high fat diet-induced non-alcoholic steatohepatitis in rats. "
06/01/2012 - "Protective effects of tiopronin against high fat diet-induced non-alcoholic steatohepatitis in rats."
06/01/2012 - "Tiopronin exerts protective effects against non-alcoholic steatohepatitis in rats, which may be associated with its antioxidant properties and regulation of lipid metabolism."
08/01/2010 - "Acupoint catgut embedding is an effective method for the treatment of non-alcoholic steatohepatitis and this therapy is superior to oral administration of Tiopronin and Xuezhikang capsule."
10/01/2014 - "Proteinuria in the nephrotic range may spontaneously remit after tiopronin withdrawal. "
06/01/2001 - "It must be emphasized that patients treated with tiopronin should be screened for proteinuria."
10/01/2014 - "Withdrawal of tiopronin-induced proteinuria complete remission and clinical resolution of nephrotic syndrome. "
02/01/1990 - "cent) discontinuation of the thiopronine because of nephrotic syndrome (3 case) and proteinuria (5 cases). "
05/01/1983 - "Pemphigus foliaceus and proteinuria induced by alpha-mercaptopropionylglycine."
06/01/2015 - "This study compares fluorescence and photoacoustic (PA) imaging of ex vivo tumors and organs from tumor-bearing mice injected intravenously with ultrasmall (<3 nm ) tiopronin-capped Au nanoparticles and compares the data with inductively coupled plasma mass spectrometry (ICP-MS). "
02/01/2013 - "This study describes the basic intracellular characteristics of Tiopronin-Au nanoparticles from the standpoint of their anti-cancer activity in different cancer cell cultures."
05/22/2012 - "Surprisingly, both 2 and 6 nm Au@tiopronin nanoparticles were distributed throughout the cytoplasm and nucleus of cancer cells in vitro and in vivo, whereas 15 nm Au@tiopronin nanoparticles were found only in the cytoplasm, where they formed aggregates. "
01/01/2011 - "Sera from cancer patients exhibited reduced meprin-α inhibition compared to healthy controls. "
01/01/2011 - "The impact of increased meprin-α levels on tumor progression is not known. "
|4.||Chronic Hepatitis (Chronic Active Hepatitis)
01/01/1982 - "The efficacy of tiopronin (2-mercaptopropionyl glycine) 600 mg daily in the treatment of chronic active or chronic persistent hepatitis has been assessed in a double-blind controlled clinical trial of 12 weeks involving 165 Japanese patients with histologically proven disease. "
01/01/1982 - "The results of this short-term study indicate that tiopronin may be of value in the treatment of chronic hepatitis."
01/01/1982 - "Therapeutic effects of tiopronin on chronic hepatitis: a double-blind clinical study."
12/01/1981 - "Follow-up study in chronic active hepatitis after therapies with immunosuppressive drugs and tiopronin."
01/01/1980 - "Having used 2-mercaptopropionylglycine in successful treatment of chronic hepatitis the mode of action of the reagent was further studied in rat liver mitochondrial membrane. "
03/01/2008 - "Targeted disruption of the meprin metalloproteinase beta gene protects against renal ischemia-reperfusion injury in mice."
03/01/2002 - "Radical shifts in the localization of an activated enzyme to potentially sensitive areas of the tubule suggest a toxic role for meprin in ischemia-reperfusion injury. "
03/01/2002 - "The second objective was to determine if inhibition of meprin is protective against hypoxia-reoxygenation injury in vitro and ischemia-reperfusion injury in vivo. "
06/01/1998 - "Since in our in vitro studies, we identified a distinct meprin-induced 55 kDa nidogen breakdown product, the urine was also examined for the presence of nidogen degradation products after rat renal ischemia-reperfusion injury. "
|10.||Glycine (Aminoacetic Acid)
|1.||Drug Therapy (Chemotherapy)
|3.||Acupuncture Points (Acupuncture Point)